Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renue By Science is a health and wellness company focused on longevity and cellular rejuvenation through advanced delivery systems for NAD+ precursors and other longevity molecules. The company specializes in liposomal formulations of Nicotinamide Mononucleotide (NMN), Nicotinamide Riboside (NR), and NAD+ to enhance bioavailability and absorption. Their product line includes sublingual tablets, intranasal sprays, and transdermal gels designed to combat age-related cellular decline. By leveraging cutting-edge research in sirtuin activation and mitochondrial health, Renue By Science provides consumers with science-backed supplements aimed at extending healthspan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renue By Science.